Archive · 23 Jul 2026
Trump unveils TrumpRx for cheaper medicines
President Donald Trump has introduced a new programme called TrumpRx, which aims to lower the cost of prescription drugs in the United States.
The programme uses a 'most favoured nation' policy, meaning that drug prices in the US will match the lowest prices available in other developed countries.
Trump claims that this will result in significant price reductions, making medicines more affordable for Americans.
He urged people to use the TrumpRx.gov platform to compare drug prices and find the best deals.
The policy involves negotiations with pharmaceutical companies and foreign governments, and Trump mentioned discussions with French President Emmanuel Macron to increase drug prices in France.
Trump believes this initiative will have a major impact on healthcare costs and could influence the upcoming midterm elections.
President Donald Trump introduced the TrumpRx programme to reduce prescription drug prices in the US.
The programme uses a 'most favoured nation' policy to match the lowest drug prices in other developed countries.
Trump claims the policy will result in significant price reductions, making medicines more affordable.
The TrumpRx.gov platform allows Americans to compare drug prices and find the best deals.
The policy involves negotiations with pharmaceutical companies and foreign governments, including discussions with French President Emmanuel Macron.
- Who
- President Donald Trump and his administration
- What
- Implementation of the TrumpRx programme to reduce prescription drug prices
- When
- During a rally in Marietta, Georgia
- Where
- United States
- Why
- To make prescription drugs more affordable for Americans by matching the lowest prices in other developed countries
Supporters of TrumpRx
Critics of TrumpRx
Effectiveness of the Policy
Supporters of TrumpRx
Supporters argue that TrumpRx will significantly reduce drug prices, making medicines more affordable for Americans.
Critics of TrumpRx
Critics question the feasibility and effectiveness of the policy, suggesting it may not lead to substantial price reductions.
Impact on Pharmaceutical Companies
Supporters of TrumpRx
Supporters believe the policy will force pharmaceutical companies to lower prices, benefiting consumers.
Critics of TrumpRx
Critics argue that the policy could harm pharmaceutical companies, potentially leading to reduced investment in research and development.
- Policy Name
- TrumpRx
- Policy Type
- Most Favoured Nation Pricing Policy
- Claimed Price Reduction
- 400-600% reduction
- Platform
- TrumpRx.gov
- Key Negotiations
- Pharmaceutical manufacturers and foreign governments
- Potential Impact
- Significant healthcare reform and potential influence on midterm elections